AC Immune (ACIU) Competitors $3.52 -0.07 (-1.95%) Closing price 04:00 PM EasternExtended Trading$3.56 +0.04 (+1.14%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACIU vs. PRAX, NUVB, COLL, WVE, ORIC, TRVI, PGEN, IMNM, CRON, and BGMShould you be buying AC Immune stock or one of its competitors? The main competitors of AC Immune include Praxis Precision Medicines (PRAX), Nuvation Bio (NUVB), Collegium Pharmaceutical (COLL), WAVE Life Sciences (WVE), Oric Pharmaceuticals (ORIC), Trevi Therapeutics (TRVI), Precigen (PGEN), Immunome (IMNM), Cronos Group (CRON), and BGM Group (BGM). These companies are all part of the "pharmaceutical products" industry. AC Immune vs. Its Competitors Praxis Precision Medicines Nuvation Bio Collegium Pharmaceutical WAVE Life Sciences Oric Pharmaceuticals Trevi Therapeutics Precigen Immunome Cronos Group BGM Group AC Immune (NASDAQ:ACIU) and Praxis Precision Medicines (NASDAQ:PRAX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership. Is ACIU or PRAX more profitable? Praxis Precision Medicines has a net margin of 0.00% compared to AC Immune's net margin of -174.94%. AC Immune's return on equity of -49.35% beat Praxis Precision Medicines' return on equity.Company Net Margins Return on Equity Return on Assets AC Immune-174.94% -49.35% -23.16% Praxis Precision Medicines N/A -60.07%-54.84% Which has better earnings & valuation, ACIU or PRAX? AC Immune has higher revenue and earnings than Praxis Precision Medicines. AC Immune is trading at a lower price-to-earnings ratio than Praxis Precision Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAC Immune$31.02M11.39-$57.83M-$0.58-6.07Praxis Precision Medicines$8.55M133.66-$182.82M-$12.29-4.42 Which has more risk and volatility, ACIU or PRAX? AC Immune has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Comparatively, Praxis Precision Medicines has a beta of 2.62, suggesting that its stock price is 162% more volatile than the S&P 500. Do analysts rate ACIU or PRAX? AC Immune presently has a consensus price target of $10.00, suggesting a potential upside of 184.09%. Praxis Precision Medicines has a consensus price target of $85.56, suggesting a potential upside of 57.59%. Given AC Immune's higher possible upside, research analysts plainly believe AC Immune is more favorable than Praxis Precision Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AC Immune 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Praxis Precision Medicines 2 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.75 Does the media prefer ACIU or PRAX? In the previous week, AC Immune and AC Immune both had 4 articles in the media. AC Immune's average media sentiment score of 0.70 beat Praxis Precision Medicines' score of 0.61 indicating that AC Immune is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AC Immune 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Praxis Precision Medicines 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of ACIU or PRAX? 51.4% of AC Immune shares are owned by institutional investors. Comparatively, 67.8% of Praxis Precision Medicines shares are owned by institutional investors. 4.6% of AC Immune shares are owned by company insiders. Comparatively, 2.7% of Praxis Precision Medicines shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryAC Immune and Praxis Precision Medicines tied by winning 8 of the 16 factors compared between the two stocks. Get AC Immune News Delivered to You Automatically Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACIU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACIU vs. The Competition Export to ExcelMetricAC ImmuneMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$360.47M$3.36B$6.11B$10.56BDividend YieldN/A2.29%5.69%4.75%P/E Ratio-6.0721.5785.4827.60Price / Sales11.39475.54621.72242.93Price / CashN/A47.1237.9261.55Price / Book2.7310.1413.136.76Net Income-$57.83M-$52.31M$3.30B$275.88M7 Day Performance15.79%6.72%5.29%3.72%1 Month Performance60.00%15.01%9.94%10.22%1 Year Performance6.34%29.34%87.78%35.86% AC Immune Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACIUAC Immune2.1634 of 5 stars$3.52-1.9%$10.00+184.1%+5.6%$360.47M$31.02M-6.07140News CoveragePositive NewsAnalyst ForecastPRAXPraxis Precision Medicines2.268 of 5 stars$52.38-0.1%$85.56+63.3%-16.7%$1.10B$8.55M-4.26110Analyst ForecastNUVBNuvation Bio2.9205 of 5 stars$3.22+0.6%$7.50+132.9%+69.3%$1.10B$7.87M-5.1160Analyst ForecastCOLLCollegium Pharmaceutical4.1655 of 5 stars$34.57+0.5%$42.33+22.5%-16.1%$1.08B$631.45M33.24210Positive NewsAnalyst ForecastWVEWAVE Life Sciences4.4739 of 5 stars$7.13+4.9%$20.33+185.2%-10.6%$1.08B$108.30M-7.92240News CoverageAnalyst ForecastORICOric Pharmaceuticals4.1771 of 5 stars$11.62+4.5%$17.29+48.8%+48.6%$1.08BN/A-6.1580News CoverageAnalyst ForecastInsider TradeTRVITrevi Therapeutics2.4935 of 5 stars$8.95+2.1%$21.75+143.0%+231.6%$1.07BN/A-21.3120News CoverageAnalyst ForecastGap UpPGENPrecigen4.5023 of 5 stars$3.63+3.4%$8.25+127.3%+289.4%$1.05B$4.34M-8.64190Analyst ForecastGap UpIMNMImmunome1.4188 of 5 stars$11.34-2.2%$23.20+104.6%+11.0%$1.01B$9.04M-3.6840Analyst ForecastGap UpCRONCronos Group0.5126 of 5 stars$2.97+12.9%N/A+19.1%$1.01B$117.61M59.40450Analyst ForecastHigh Trading VolumeBGMBGM Group0.2453 of 5 stars$9.61-5.4%N/A+32.6%$987.78M$25.10M0.00298News CoverageAnalyst ForecastGap Up Related Companies and Tools Related Companies Praxis Precision Medicines Competitors Nuvation Bio Competitors Collegium Pharmaceutical Competitors WAVE Life Sciences Competitors Oric Pharmaceuticals Competitors Trevi Therapeutics Competitors Precigen Competitors Immunome Competitors Cronos Group Competitors BGM Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACIU) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AC Immune Please log in to your account or sign up in order to add this asset to your watchlist. Share AC Immune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
